Frequency Therapeutics
Latest round
- Series C
Last raised
- Jul 2019
Total raised
- $136M
Investors
- 13
About Frequency Therapeutics
Founded in 2015 and based in Massachusetts, US, Frequency Therapeutics, Inc. is a clinical-stage biotechnology company that develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. It enables disease modification without the complexity of genetic engineering. The company's platform regenerates sensory cells in the inner ear to heal chronic noise-induced hearing loss and develops products for eye and skin infirmities, gastrointestinal ailments, and diabetes.
Who invested in Frequency Therapeutics
13 investors across 3 rounds
See all investors in Frequency Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Frequency Therapeutics
Who invested in Frequency Therapeutics?
Frequency Therapeutics has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Frequency Therapeutics raised?
Frequency Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Frequency Therapeutics last raise money?
Frequency Therapeutics's most recent round on record is a Series C, in Jul 2019.
What does Frequency Therapeutics do?
Founded in 2015 and based in Massachusetts, US, Frequency Therapeutics, Inc.
Where is Frequency Therapeutics headquartered?
Frequency Therapeutics is headquartered in Woburn, US.
Which VCs invest in companies like Frequency Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Frequency Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Frequency Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.